Floatz logo

Captopril

Type 2 Diabetes Mellitus

Cairo UniversitySmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

135 Active assets in the Type 2 Diabetes Mellitus cohort.

Asset / SponsorPhaseRating
Liraglutide
RenJi Hospital
Phase 4BBB
Exenatide
Vivani Medical, Inc
Phase 4BBB
Dapagliflozin
Bhavya Bhavya, MD
Phase 4BBB
Cotadutide
AstraZeneca
Phase 2BBB
Semaglutide
Shanghai Jiao Tong University School of Medicine
Phase 4BBB

View all 49 →

Same molecule, other indications

Captopril is also rated in:

kidney failureDormant
BB
Indicative · Phase 4
64 / 100
View asset →
bone cancerDormant
BB
Indicative · Phase 3
64 / 100
View asset →
childhood acute myeloid leukemiaDormant
B
Indicative · Phase 3
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →